DLAT Antikörper (C-Term)
Kurzübersicht für DLAT Antikörper (C-Term) (ABIN631076)
Target
Alle DLAT Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- DLAT antibody was raised against the C terminal of DLAT
-
Aufreinigung
- Affinity purified
-
Immunogen
- DLAT antibody was raised using the C terminal of DLAT corresponding to a region with amino acids DVVSLATKAREGKLQPHEFQGGTFTISNLGMFGIKNFSAIINPPQACILA
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
DLAT Blocking Peptide, (ABIN937613), is also available for use as a blocking control in assays to test for specificity of this DLAT antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of DLAT antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- DLAT (Dihydrolipoyl Transacetylase (DLAT))
-
Andere Bezeichnung
- DLAT
-
Hintergrund
- DLAT is dihydrolipoamide acetyltransferase, the E2 subunit of the mammalian pyruvate dehydrogenase complex of the inner mitochondrial membrane. Patients with primary biliary cirrhosis show autoantibodies to DLAT.
-
Molekulargewicht
- 69 kDa (MW of target protein)
Target
-